For your programme
Advance a programme.
Resolve molecular questions and develop useful chemistry, connecting scientific expertise with your existing evidence.
Explore programme collaborationKuano / Science, connected
Molecular understanding.
New possibilities for discovery.
Kuano combines quantum physics-based molecular design with an agent-enabled scientific platform for drug discovery and molecular innovation.
We work with small biotechs and chemistry discovery teams, pharmaceutical companies, CROs and other R&D organisations, from focused scientific questions to broader programmes and integrated capabilities.
For your organisation
Build a capability.
Access selected Kuano tools and workflows, or work with us to develop scientific infrastructure within your organisation.
Explore the platformPartnerships
Work with Kuano.
Scientific collaboration, selected capabilities, infrastructure and joint offerings.
Explore partnershipsWhere we contribute
What would progress look like for you?
Make sense of the evidence.
You have compounds and experimental results, but important questions about models, binding or mechanism remain. Connect that evidence to interpretations you can test.
Open a new design direction.
Your programme needs differentiated chemistry or a better explanation of molecular behaviour. Use scientific insight to guide the next designs and experiments.
Establish repeatable capability.
Your teams need to apply scientific methods across projects. Bring tools, data and computation into coordinated workflows, with a deployment approach suited to your organisation.
The Kuano platform
Scientific methods, computation
and evidence, connected.
Kuano scientists use the platform in their own work. It also provides a foundation for selected capabilities and infrastructure developed with clients.
Quantum Lens holds the scientific methods and workflows. Compute runs the work; the Database retains chemistry, context and experiment provenance.
Agentic orchestration layer
Software agents coordinate steps across scientific tools, Compute and the project record, under scientist direction and review.
Our aim is to help specialist expertise support more programmes while making methods and analysis easier to share across discovery teams. Scientists retain control over assumptions and interpretation.
Scientific evidence
From mechanism to molecular insight.
Design followed by experimental testing
Experimentally tested chemistry
DNMT1
Mechanistic insight informed new inhibitor chemistry, followed by experimental assessment.
Read the caseMechanistic design & testing
NOTUM
A transient reaction feature informed molecular design and experimentally tested inhibitor chemistry.
Read the caseInterpretation of existing evidence
Retrospective analysis
JAK3
Quantum analysis examined covalent behaviour in the protein environment using published ligands.
Read the caseScientific focus
Understand the molecule.
Explore the design possibilities.
01
Enzyme mechanisms
Investigate reaction pathways and transition states to identify opportunities for molecular design.
02
Covalent design
Examine reactivity alongside binding geometry and the molecular environment.
03
Selectivity
Understand why related compounds or targets behave differently, and use that insight to guide design.
04
Binding and difficult pockets
Explore molecular dynamics, candidate binding sites and structural hypotheses against available evidence.
Research & updates
Explore the work behind the science.
Read selected publications, funded research and company updates.
Explore publications and funded projects
Kuano joins the pharma and AI conversation at Life Sciences Week
Vid Stojevic joined a Birmingham panel exploring how pharma and AI companies can build effective partnerships.
Read the update
Kuano demonstrates its agent-supported platform in Singapore
At Asia Bio Partnering Forum, Kuano showed how its agent-supported platform can help plan, run and analyse a computational study.
Read the update Watch the demo
Kuano at BIO International Convention in San Diego
Kuano joined the global biotech community in San Diego for discussions on computational approaches to drug discovery.
Read the update
From discussion to demonstration: agentic AI in drug discovery
Our King’s Cross event brought together perspectives from pharma, AI, chemistry and investment, alongside a Kuano demonstration of covalent binder design workflows.
Read the update
Kuano in MedNous! Redefining Drug Discovery with the Quantum Lens
Kuano in MedNous! We’re thrilled to be featured in this month’s edition. You can read the article entitled ‘Redefining Drug Discovery using Quantum Physics’. At Kuano, we’re bringing quantum…
Read the update
Kuano at Discovery On Target in Boston
If you missed Kuano’s poster at Discovery On Target in Boston last month, it is now available on our website here.
Read the updateWork with Kuano
Start with the outcome you need.
A contribution shaped around your team.
Agree the scientific question, resources and responsibilities. Work alongside your own specialists and experimental partners, with scope to develop the collaboration as the evidence grows.